Category: Medications - Page 2
Five Essential Rules for Taking Medication Safely
Finnegan O'Sullivan Jan 11 14Learn the five essential rules for taking medication safely to avoid dangerous errors, interactions, and overdoses. Practical, proven advice for managing prescriptions at home and in clinical settings.
More Detail
The 80-125% Rule: Understanding Bioequivalence Confidence Intervals in Generic Drugs
Finnegan O'Sullivan Jan 10 8The 80-125% rule ensures generic drugs work like brand-name versions by comparing how much drug enters the bloodstream. It's not about pill strength - it's about absorption. Here's how it works and why it matters.
More Detail
Medication Recalls: What Patients Should Do Immediately
Finnegan O'Sullivan Jan 4 10When a medication is recalled, don't panic or stop taking it. Learn the immediate steps to take-checking lot numbers, contacting your pharmacy, safely disposing of pills, and when to call your doctor. Stay safe with clear, actionable advice.
More Detail
Out-of-Pocket Costs: How Generics Slash Your Medication Bills
Finnegan O'Sullivan Jan 3 14Generic drugs cut prescription costs by up to 90%, yet most people still overpay due to opaque pricing. Learn how to save hundreds annually by switching to generics and using direct-to-consumer pharmacies.
More Detail
Healthcare System Savings: How Generic Drugs Cut U.S. Drug Costs by Hundreds of Billions
Finnegan O'Sullivan Jan 1 15Generic drugs saved $482 billion in U.S. healthcare spending in 2024, making up 90% of prescriptions but just 12% of costs. Biosimilars are the next frontier in cutting drug prices - if we remove the barriers holding them back.
More Detail
Generic Drug Savings: Real Numbers and National Statistics
Finnegan O'Sullivan Dec 31 11Generic drugs saved $467 billion in the U.S. in 2024 alone - but most people don’t realize how much they’re saving. See the real numbers behind generic vs. brand-name drug costs, biosimilar growth, and why these savings are at risk.
More Detail
Reimbursement and Coding for Biosimilars: How Billing Works Under Medicare Part B
Finnegan O'Sullivan Dec 29 9Biosimilars are billed differently than generics under Medicare Part B. Each has its own HCPCS code and payment rate based on its ASP plus 6% of the reference product's price. This system affects provider choices, patient costs, and adoption rates.
More Detail
Non-formulary generics: what to do when coverage is denied
Finnegan O'Sullivan Dec 27 8When your insurance denies coverage for a generic drug, you don't have to pay full price or go without. Learn how to use the legal exceptions process to get your medication covered - with real data, step-by-step guidance, and proven strategies.
More Detail
How to Build Patient Confidence in Generic Medications: Proven Strategies Based on Research
Finnegan O'Sullivan Dec 24 12Generic drugs save billions but many patients still distrust them. Learn research-backed ways providers and pharmacists can build confidence through clear, empathetic communication.
More Detail
Market Exclusivity Extensions: How Pharma Companies Extend Monopolies Beyond Patents
Finnegan O'Sullivan Dec 23 12Market exclusivity extensions let pharmaceutical companies delay generic competition long after patents expire, using regulatory tools like orphan drug and pediatric exclusivity. These mechanisms add years to monopolies, costing billions in extra healthcare spending.
More Detail